107 related articles for article (PubMed ID: 17094477)
1. Neurotensin receptors in adeno- and squamous cell carcinoma.
Haase C; Bergmann R; Oswald J; Zips D; Pietzsch J
Anticancer Res; 2006; 26(5A):3527-33. PubMed ID: 17094477
[TBL] [Abstract][Full Text] [Related]
2. Expression of neurotensin receptors in human corneal keratocytes.
Bourcier T; Rondeau N; Paquet S; Forgez P; Lombet A; Pouzaud F; Rostène W; Borderie V; Laroche L
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1765-71. PubMed ID: 12036977
[TBL] [Abstract][Full Text] [Related]
3. Molecular cloning and functional characterization of a type-I neurotensin receptor (NTR) and a novel NTR from the bullfrog brain.
Li JH; Sicard F; Salam MA; Baek M; LePrince J; Vaudry H; Kim K; Kwon HB; Seong JY
J Mol Endocrinol; 2005 Jun; 34(3):793-807. PubMed ID: 15956348
[TBL] [Abstract][Full Text] [Related]
4. L-type amino acid transporters LAT1 and LAT4 in cancer: uptake of 3-O-methyl-6-18F-fluoro-L-dopa in human adenocarcinoma and squamous cell carcinoma in vitro and in vivo.
Haase C; Bergmann R; Fuechtner F; Hoepping A; Pietzsch J
J Nucl Med; 2007 Dec; 48(12):2063-71. PubMed ID: 18056335
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal hormone receptors in primary human colorectal carcinomas.
Chao C; Tallman ML; Ives KL; Townsend CM; Hellmich MR
J Surg Res; 2005 Dec; 129(2):313-21. PubMed ID: 16051276
[TBL] [Abstract][Full Text] [Related]
6. Neurotensin receptor 1 determines the outcome of non-small cell lung cancer.
Alifano M; Souazé F; Dupouy S; Camilleri-Broët S; Younes M; Ahmed-Zaïd SM; Takahashi T; Cancellieri A; Damiani S; Boaron M; Broët P; Miller LD; Gespach C; Regnard JF; Forgez P
Clin Cancer Res; 2010 Sep; 16(17):4401-10. PubMed ID: 20810387
[TBL] [Abstract][Full Text] [Related]
7. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma.
Kim CH; Kim J; Kahng H; Choi EC
Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073
[TBL] [Abstract][Full Text] [Related]
8. Expression of neurotensin and its receptors in pituitary adenomas.
Giorgi RR; Chile T; Bello AR; Reyes R; Fortes MA; Machado MC; Cescato VA; Musolino NR; Bronstein MD; Giannella-Neto D; Corrêa-Giannella ML
J Neuroendocrinol; 2008 Sep; 20(9):1052-7. PubMed ID: 18624930
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptors may act in a paracrine manner to regulate oesophageal adenocarcinoma growth.
Awan AK; Iftikhar SY; Morris TM; Clarke PA; Grabowska AM; Waraich N; Watson SA
Eur J Surg Oncol; 2007 Jun; 33(5):561-8. PubMed ID: 17254742
[TBL] [Abstract][Full Text] [Related]
10. [Effects of antisense 6 gene on colon cancer cells].
Zhang ZY; Xu KS; Yang GY; Wang JS; Gao Y; Liu YF; Shuai J; Wang JY; Li SY; Shou NH; Niu J
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2645-8. PubMed ID: 18162155
[TBL] [Abstract][Full Text] [Related]
11. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
[TBL] [Abstract][Full Text] [Related]
12. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
Itashiki Y; Harada K; Ferdous T; Yoshida H
Anticancer Res; 2007; 27(4B):2365-75. PubMed ID: 17695527
[TBL] [Abstract][Full Text] [Related]
13. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
Zhang W; Chen Y; Wei H; Zheng C; Sun R; Zhang J; Tian Z
Clin Cancer Res; 2008 Oct; 14(20):6432-9. PubMed ID: 18927282
[TBL] [Abstract][Full Text] [Related]
14. Double-stabilized neurotensin analogues as potential radiopharmaceuticals for NTR-positive tumors.
García-Garayoa E; Maes V; Bläuenstein P; Blanc A; Hohn A; Tourwé D; Schubiger PA
Nucl Med Biol; 2006 May; 33(4):495-503. PubMed ID: 16720241
[TBL] [Abstract][Full Text] [Related]
15. Increased neurotensin receptor-1 expression during progression of colonic adenocarcinoma.
Gui X; Guzman G; Dobner PR; Kadkol SS
Peptides; 2008 Sep; 29(9):1609-15. PubMed ID: 18541341
[TBL] [Abstract][Full Text] [Related]
16. Reduced hGC-1 protein expression is associated with malignant progression of colon carcinoma.
Liu W; Liu Y; Zhu J; Wright E; Ding I; Rodgers GP
Clin Cancer Res; 2008 Feb; 14(4):1041-9. PubMed ID: 18281536
[TBL] [Abstract][Full Text] [Related]
17. Intermolecular cross-talk between NTR1 and NTR2 neurotensin receptor promotes intracellular sequestration and functional inhibition of NTR1 receptors.
Hwang JR; Baek MW; Sim J; Choi HS; Han JM; Kim YL; Hwang JI; Kwon HB; Beaudet N; Sarret P; Seong JY
Biochem Biophys Res Commun; 2010 Jan; 391(1):1007-13. PubMed ID: 19968961
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of axin downregulates TCF-4 and inhibits the development of lung cancer.
Xu HT; Wei Q; Liu Y; Yang LH; Dai SD; Han Y; Yu JH; Liu N; Wang EH
Ann Surg Oncol; 2007 Nov; 14(11):3251-9. PubMed ID: 17768662
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effects of Nafamostat mesilate on head and neck squamous cell carcinoma.
Yamashita Y; Ishiguro Y; Sano D; Kimura M; Fujita K; Yoshida T; Horiuchi C; Taguchi T; Matsuda H; Mikami Y; Tsukuda M
Auris Nasus Larynx; 2007 Dec; 34(4):487-91. PubMed ID: 17337140
[TBL] [Abstract][Full Text] [Related]
20. Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma.
Gockel I; Schimanski CC; Heinrich C; Wehler T; Frerichs K; Drescher D; von Langsdorff C; Domeyer M; Biesterfeld S; Galle PR; Junginger T; Moehler M
BMC Cancer; 2006 Dec; 6():290. PubMed ID: 17176471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]